Abstracts - faqs.org

Abstracts

Zoology and wildlife conservation

Search abstracts:
Abstracts » Zoology and wildlife conservation

Association of a chromosome deletion syndrome with the fragile site within the proto-oncogene CBL2

Article Abstract:

The human proto-oncogene CBL2 has a p(CCG)n repeat that is found near the folate-sensitive fragile site FRA11B. In most of the chromosomes which do not express FRA11B,the p(CCG)n repeat length (n) is eleven. When p(CCG)n repeat near the fragile site expands past certain limits, the CpG island near FRA11B is methylated. The breakpoint of the deletion in chromosome 11 in two out of five Jacobsen syndrome patients is in the region which contains FRA11B. Thus, there is an association between the expansion of the p(CCG)n repeat length in the presence of the fragile site and chromosome truncation in Jacobsen syndrome.

Author: Jones, C., Baker, E., Sutherland, G.R., Tunnacliffe, A., Penny, L., Mattina, T., Yu, S., Voullaire, L., Langdon, W.Y., Richards, R.I.
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1995
Causes of, Chromosome deletion

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Proto-oncogene PML controls genes devoted to MHC class I antigen presentation

Article Abstract:

Immune responses are elicited by presenting fragments of foreign antigens linked to class I molecules of the major histocompatibility complex. Such presentation needs several genes contained in the MHC to be coordinately expressed, including those encoding the proteins LMP-2 and LMP-7. A new study shows the expression of LMP-2, LMP-7, TAP-1 and TAP-2 induced by proto-oncogene product PML. It is suggested that PML malfunction may enable a tumor to evade the body's immune system.

Author: Levy, David E., Dyck, Jacqueline A., Liu, Yang, Guo, Yong, Zheng, Pan, Niu, Qingtian, Lu, Shengli, Sheiman, Lori A.
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1998
Genetic aspects, Tumors

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Wavering on commitment

Article Abstract:

Nutt and colleagues and Rolink and colleagues have challenged current ideas on how immature cells are committed to producing specific types of progeny cells. Rolink and colleagues found that Pax5-deficient clones were able to fully reconstitute T-cell development in immunodeficient mice. Nutt and colleagues found that pre-BI cells from Pax5-deficient mice could not differentiate into B cells on IL-7 depletion, unless Pax5 expression was restored.

Author: Cory, Suzanne
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1999
Lymphocytes

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, Proto-oncogenes, Observations, Immunological research, Immunologic research
Similar abstracts:
  • Abstracts: Observational confirmation of a circumsolar dust ring by the COBE satellite. Re-entry and ablation of cometary dust in the impact plumes of Shoemaker-Levy 9
  • Abstracts: Sequence variation of the human Y chromosome. The nuclear hormone receptor SEX-1 is an X-chromosome signal that determines nematode sex
  • Abstracts: Is speciation no accident? Speciation without isolation. The complete genome sequence of the Gram-positive bacterium Bacillus subtilis
  • Abstracts: When three is a crowd. Long-term decline in krill stock and increase in salps within the Southern Ocean
  • Abstracts: Sources and contribution of terrigenous organic carbon to surface sediments in the Gulf of Mexico. part 2 Rapid accumulation and turnover of soil carbon in a re-establishing forest
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2023 Advameg, Inc.